The Prognosis of ARID I A Gene Expression in Colon Cancer Patients and sensitivity of ATR Inhibitors

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200060520

Enrollment

Unknown

Registered

2022-06-04

Start date

2022-05-26

Completion date

Unknown

Last updated

2024-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colon cancer

Interventions

Case series:None

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients who underwent resection of primary colon cancer tumors at Mianyang Fulin Hospital from May 2022 to July 2025.

Exclusion criteria

Exclusion criteria: 1. Patients who received preoperative chemotherapy or preoperative radiation therapy; 2. Patients who did not want to participate in this study.

Design outcomes

Primary

Measure	Time frame
Tumor cells viability ratio;	—

Countries

China

Contacts

Public ContactKang Mingwei

MianYang Fulin Hospital

137205274@qq.com+86 13730701094

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026